GlassScriptPhysician profile
Tasha C Shamlin
NPI 1568468296
$3,910.73
in general payments reported to CMS, 2019-2025
38 companies · $465 in 2025
The $465 reported for 2025 was more than what 93% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,898 · 2020: $358 · 2021: $619 · 2022: $12.10 · 2023: $86.04 · 2024: $473 · 2025: $465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,024.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,024.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $594.90 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $528.83 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $446.58 | 2019-2025 | Farxiga, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $374.94 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $258.79 | 2019-2024 | Capvaxive, Gardasil, Gardasil 9 |
| Sanofi-Aventis U.S. LLC | $254.75 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $195.05 | 2019-2021 | |
| Si-Bone, INC. | $149.22 | 2019 | |
| Abbvie INC. | $102.37 | 2019-2021 | |
| Abbott Laboratories | $102.10 | 2024-2025 | Freestyle Libre 3 |
| Kowa Pharmaceuticals America, INC. | $100.25 | 2019-2025 | Zoryve |
| Amgen INC. | $72.04 | 2019-2021 | |
| Genentech USA, INC. | $64.02 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $59.54 | 2019-2020 | |
| Medtronic, INC. | $50.55 | 2021-2025 | Minimed 780g |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tasha Shamlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.